Your browser doesn't support javascript.
loading
Global identification of SWI/SNF targets reveals compensation by EP400.
Martin, Benjamin J E; Ablondi, Eileen F; Goglia, Christine; Mimoso, Claudia A; Espinel-Cabrera, Piero R; Adelman, Karen.
Affiliation
  • Martin BJE; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA.
  • Ablondi EF; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Goglia C; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Mimoso CA; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Espinel-Cabrera PR; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Adelman K; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: karen_adelman@hms.harvard.edu.
Cell ; 186(24): 5290-5307.e26, 2023 11 22.
Article in En | MEDLINE | ID: mdl-37922899
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Nuclear Proteins Limits: Animals / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Nuclear Proteins Limits: Animals / Humans Language: En Year: 2023 Type: Article